Cite
Gonzalez-Junca A, Liu FD, Nagaraja AS, et al. SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors. Mol Cancer Ther. 2021;20(9):1508-1520doi: 10.1158/1535-7163.MCT-21-0030.
Gonzalez-Junca, A., Liu, F. D., Nagaraja, A. S., Mullenix, A., Lee, C. T., Gordley, R. M., Frimannsson, D. O., Maller, O., Garrison, B. S., Iyer, D., Benabbas, A., Truong, T. A., Quach, A., Tian, M., Martinez, R., Savur, R., Perry-McNamara, A., Nguyen, D., Almudhfar, N., Blanco, C., Huynh, C., Nand, A., Lay, Y. E., Magal, A., Mangalampalli, S., Lee, P. J., Lu, T. K., Lee, G., Whitt-Glover, M. C., & Marquez, D. X. (2021). SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors. Molecular cancer therapeutics, 20(9), 1508-1520. https://doi.org/10.1158/1535-7163.MCT-21-0030
Gonzalez-Junca, Alba, et al. "SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors." Molecular cancer therapeutics vol. 20,9 (2021): 1508-1520. doi: https://doi.org/10.1158/1535-7163.MCT-21-0030
Gonzalez-Junca A, Liu FD, Nagaraja AS, Mullenix A, Lee CT, Gordley RM, Frimannsson DO, Maller O, Garrison BS, Iyer D, Benabbas A, Truong TA, Quach A, Tian M, Martinez R, Savur R, Perry-McNamara A, Nguyen D, Almudhfar N, Blanco C, Huynh C, Nand A, Lay YE, Magal A, Mangalampalli S, Lee PJ, Lu TK, Lee G, Whitt-Glover MC, Marquez DX. SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors. Mol Cancer Ther. 2021 Sep;20(9):1508-1520. doi: 10.1158/1535-7163.MCT-21-0030. Epub 2021 Jul 01. PMID: 34210826.
Copy
Download .nbib